Retinal Vein Occlusion Completed Phase 2 / 3 Trials for Niacin (DB00627)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00493064To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein OcclusionsTreatment